AKTS
Price
$19.00
Change
-$1.90 (-9.09%)
Updated
Feb 4, 02:19 PM (EDT)
Capitalization
1.09B
Intraday BUY SELL Signals
CRDO
Price
$96.24
Change
-$15.07 (-13.54%)
Updated
Feb 4, 02:33 PM (EDT)
Capitalization
20.11B
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AKTS vs CRDO

Header iconAKTS vs CRDO Comparison
Open Charts AKTS vs CRDOBanner chart's image
Aktis Oncology
Price$19.00
Change-$1.90 (-9.09%)
Volume$300
Capitalization1.09B
Credo Technology Group Holding
Price$96.24
Change-$15.07 (-13.54%)
Volume$5.4K
Capitalization20.11B
AKTS vs CRDO Comparison Chart in %
View a ticker or compare two or three
VS
AKTS vs. CRDO commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKTS is a StrongBuy and CRDO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (AKTS: $20.90 vs. CRDO: $111.31)
Brand notoriety: AKTS and CRDO are both not notable
AKTS represents the Biotechnology, while CRDO is part of the Semiconductors industry
Current volume relative to the 65-day Moving Average: AKTS: 61% vs. CRDO: 177%
Market capitalization -- AKTS: $1.09B vs. CRDO: $20.11B
AKTS [@Biotechnology] is valued at $1.09B. CRDO’s [@Semiconductors] market capitalization is $20.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The market cap for tickers in the [@Semiconductors] industry ranges from $4.38T to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B. The average market capitalization across the [@Semiconductors] industry is $104.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKTS’s FA Score shows that 0 FA rating(s) are green whileCRDO’s FA Score has 0 green FA rating(s).

  • AKTS’s FA Score: 0 green, 5 red.
  • CRDO’s FA Score: 0 green, 5 red.
According to our system of comparison, AKTS is a better buy in the long-term than CRDO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDO’s TA Score shows that 3 TA indicator(s) are bullish.

  • CRDO’s TA Score: 3 bullish, 6 bearish.

Price Growth

AKTS (@Biotechnology) experienced а -1.51% price change this week, while CRDO (@Semiconductors) price change was -14.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

The average weekly price growth across all stocks in the @Semiconductors industry was -6.03%. For the same industry, the average monthly price growth was +0.74%, and the average quarterly price growth was +36.39%.

Reported Earning Dates

CRDO is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Semiconductors (-6.03% weekly)

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRDO($20.1B) has a higher market cap than AKTS($1.09B).
AKTSCRDOAKTS / CRDO
Capitalization1.09B20.1B5%
EBITDAN/A225M-
Gain YTDN/A-22.642-
P/E RatioN/A95.96-
RevenueN/A796M-
Total CashN/A814M-
Total DebtN/A16.4M-
FUNDAMENTALS RATINGS
AKTS: Fundamental Ratings
AKTS
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
59
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRDO
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 8 days ago
89%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CRDO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UFO45.611.09
+2.45%
Procure Space ETF
BKAG42.300.01
+0.01%
BNY Mellon Core Bond ETF
XVOL23.55N/A
N/A
Acruence Active Hedge US Equity ETF
FLCC32.69N/A
N/A
Federated Hermes MDT Large Cap Core ETF
UJUN37.62-0.06
-0.17%
Innovator U.S. Equity Ultra BffrETF™-Jun

AKTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKTS has been loosely correlated with CGON. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if AKTS jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKTS
1D Price
Change %
AKTS100%
-4.91%
CGON - AKTS
34%
Loosely correlated
-3.28%
NBY - AKTS
33%
Loosely correlated
-32.16%
ZNTL - AKTS
27%
Poorly correlated
+12.35%
SPRY - AKTS
27%
Poorly correlated
-1.46%
CRDO - AKTS
24%
Poorly correlated
-7.21%
More

CRDO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRDO has been closely correlated with ALAB. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRDO jumps, then ALAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDO
1D Price
Change %
CRDO100%
-7.21%
ALAB - CRDO
70%
Closely correlated
+3.99%
NVDA - CRDO
68%
Closely correlated
-2.84%
AVGO - CRDO
67%
Closely correlated
-3.26%
MTSI - CRDO
66%
Closely correlated
-0.81%
TSM - CRDO
64%
Loosely correlated
-1.64%
More